Search
for
Sort by
Research 91–120 of 1000+
- Office Dermatology
- Spectrum and clinical burden of Unrecognized Dermatologic Diseases in hospitalized adults: A single-centre cross-sectional study
- Do Dermatoses Trigger Neurodegenerative Diseases? A Retrospective Observational Study
- As manifestações dermatológicas da síndrome do ovário policístico: Uma revisão bibliográfica
- Assessment of Dermatological Disorders with Chronic Hepatitis C Virus Infection
- Clinical spectrum of ageing versus non-ageing geriatric dermatoses -A case-controlled study in tertiary care centre, Tamil Nadu, South India
- ANDROGEN-DEPENDENT DERMOPATHY IN WOMEN WITH KELOID SCARS
- Dermatological Benefits of Cosmetics
- Treatment of acne with intermittent isotretinoin, cohort study
- Festschrift in honor of the 65th birthday of Dr. Howard I. Maibach
- The sebaceous gland revisited: Friend and adversary
- Alopecia: A Pathologist's View
- A clinical study of geriatric dermatoses
- A CLINICAL STUDY OF GERIATRIC DERMATOSES
- Cutaneous manifestations of polycystic ovary syndrome: A cross-sectional clinical study
- Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Botulinum Toxin Off-Label Use in Dermatology: A Review
- Polycystic ovarian syndrome
- Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients
- Factors affecting the course and severity of adult acne. Observational cohort study
- DERMATOLOGICAL ASPECTS OF SIGNIFICANCE OF HYPERANDROGENIZM FOR POLYCYSTIC OVARY SYNDROME
- Study of Cutaneous Manifestations in Patients with Polycystic Ovarian Syndrome Attending a Tertiary Care Centre
- Neuroendokrine paraneoplastische Syndrome
- Hyperinsulinism, Insulin Resistance and Fertility
- 1340 低熱セメントを用いた高強度コンクリート実大施工実験 : その4 硬化コンクリートの性状
- PHARMACOLOGICAL BASIS FOR CLINICAL USE OF ANTIANDROGENS
- [Anti-androgens. Their use in dermatology].
- Female androgenetic alopecia with male pattern caused by an androgen-producing tumor
- Daclizumab